Disparities and Trends in Viral Suppression During a Transition to a “Test and Treat” Approach to the HIV Epidemic, San Francisco, 2008–2012

Abstract

We found a decrease in time and overall population-level increases in viral suppression under a test and treat strategy and highlight sociodemographic disparities that may hamper the full benefit of this approach.

Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009–2013

“…Regarding Hispanic-white disparities, many [2, 3, 6, 21, 22, 25], though not all [4, 23, 24], found no significant Hispanic-white difference in ART use. Across varying populations, most studies find black-white disparities in viral suppression [4–7, 21, 25–28]. Only one recent analysis found no black-white differences in time to viral suppression among a large cohort of persons newly eligible for ART [3].…”

“…Only one recent analysis found no black-white differences in time to viral suppression among a large cohort of persons newly eligible for ART [3]. Among recent studies, all but one [4] found no differences between Hispanics and whites in viral suppression [3, 6, 7, 21, 25, 26]. Adjudicating between these disparate findings can be challenging due to different study populations, measurement of outcomes, and adjustment factors.…”

Sexually transmitted infections: challenges ahead

“…The Organisation for 395 Economic Cooperation and Development (OECD) collates hospital discharge by diagnostic 396 categories for its member countries. 122 Figure 5 shows data for "inflammatory diseases of 397 female pelvic organs", which includes PID from any cause (supplement Future challenges for the control of chlamydia 414 Shift of focus from monitoring test uptake to measuring PID incidence 415 To date, chlamydia control strategies in several high income countries promote screening for 416 asymptomatic infection with a focus on monitoring chlamydia test uptake and chlamydia 417 prevalence. It is surprising therefore, that limited attention has been given to monitoring PID 418 incidence and its complications given that prevention of PID and its associated complications 419 is a key goal of chlamydia control.…”

Relationship Dynamics and Partner Beliefs About Viral Suppression: A Longitudinal Study of Male Couples Living with HIV/AIDS (The Duo Project)

“…As of 2013, an estimated 72% of people living with HIV in San Francisco were virally suppressed (67) and the time to viral suppression among newly diagnosed San Franciscans decreased significantly following the adoption of universal ART in 2010 (68). While Duo participants were recruited throughout the greater San Francisco Bay Area, including areas that have not implemented a TasP approach, the study population may be more likely to be virally suppressed today—surpassing the 50% viral suppression rate we found and more in line with what their partners believed (upwards of 73% believed that their partners were suppressed).…”